CNN Money Top Stories

if you're looking for the ultimate sports car experience, McLaren's latest is about as good as it gets.

In Sun City, Arizona, tax reform, Social Security and Medicare are on the minds of a powerful bloc of senior voters ahead of the special election for the 8th congressional district Tuesday.

Judge Leon has more than a binary option -- to stop the deal or not. He has some leverage, according to antitrust experts and former Justice Department officials.

Julie Sweet, Accenture's CEO of North America, tells CNN's Boss Files she wants to accomplish what most other executives at major companies have not: Making sure men and women are represented equally in the company's ranks.

The Denver Post has often covered Michael Hancock critically, but the mayor doesn't want to see his hometown paper die.

President Donald Trump often repeats, almost verbatim, what Fox News personalities say on air.

The message comes one day after US Treasury Secretary Steven Mnuchin said he would consider a trip to China, and is "cautiously optimistic" the United States could broker a trade deal with Beijing.

An expected deluge of hurricane-related foreclosures has so far been avoided, thanks in part to new provisions by federal agencies and regulations imposed after the financial crisis.

The American newspaper industry says tariffs on Canadian paper could force it to cut jobs, drop pages or print fewer editions. Some are worried that smaller papers might not survive.

Read full story for latest details.

"Avengers: Infinity War" may have a box office match up with "Star Wars: The Force Awakens" for biggest opening of all time.

Read full story for latest details.

Read full story for latest details.

Read full story for latest details.

ZTE has lashed out at the US government's move to prevent it from buying technology from American companies.

Consumers have been scared off by juice's high calorie count and sugar content, and they've been lured away by beverages that offer health benefits or a caffeine boost.

Read Quest's Profitable Moment.

Here's what you need to know about the markets before you start your business day.

Drug-making giant Allergan says it has no plans to make a massive bid for biotech firm Shire, the latest twist in a saga that has played havoc with the companies' share prices.

The job cuts in California by the US chipmaker are part of layoffs it's carrying out around the world.